Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 6, 1996, Pages 886-889

  Nakamura, Shigeo ^a   Minamino, Tomoyoshi ^b   Nomura, Masaaki ^b   Wakusawa, Shinya ^b   Miyamoto, Ken Ichi ^b,d   Hidaka, Hiroyoshi ^c  

^a Fuji Yakuhin Co Ltd   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

AH66 cell; H 87; multidrug resistance; overcoming effect; P glycoprotein; rat ascites hepatoma

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; ISOQUINOLINE DERIVATIVE; MITOMYCIN; N [2 [N [3 (4 CHLOROPHENYL) 1 METHYL 2 PROPENYL]AMINO]ETHYL] 5 ISOQUINOLINESULFONAMIDE; SULFONAMIDE; UNCLASSIFIED DRUG; VINBLASTINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG POTENTIATION; DRUG RESPONSE; DRUG TRANSPORT; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; NONHUMAN; RAT;

EID: 0029982843     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.886     Document Type: Article

References (23)

1. Ford J. M., Hait W. N., Pharmacol. Rev., 42, 155 (1990).
2. Borst P., Rev. Oncol., 4, 87 (1991).
3. Mattern J., Volm M., Int. J. Oncol., 2, 557 (1993).
4. Yoshida T., Ann. N. Y. Acad. Sci., 63, 852 (1956).
5. Ichimura H., Gann to Kagakuryoho, 2, 605 (1975).
6. Miyamoto K., Wakusawa S., Nakamura S., Biochem. Pharmacol., 43, 1143 (1992).
7. Wakusawa S., Nakamura S., Inoko K., Miyamoto K., Chem. Pharm. Bull., 40, 2182 (1992).
8. Miyamoto K., Wakusawa S., Nakamura S., Tajima K., Hidaka H., Anticancer Res., 12, 649 (1992).
9. Hidaka H., Kobayashi R., Ann. Rev. Pharmacol. Toxicol., 32, 377 (1992).
10. Miyamoto K., Wakusawa S., Nakamura S., Koshiura R., Ohtsuka K., Naito K., Hagiwara M., Hidaka H., Cancer Lett., 51, 37 (1990).
11. Wakusawa S., Nakamura S., Tajima K., Miyamoto K., Hagiwara M., Hidaka H., Mol. Pharmacol., 41, 1034 (1992).
12. Nakamura S., Wakusawa S., Tajima K., Miyamoto K., Hagiwara M., Hidaka H., J. Pharm. Pharmacol., 45, 268 (1993).
13. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y., Biochemistry, 23, 5036 (1984).
14. Sanae F., Miyamoto K., Koshiura R., Cancer Res., 49, 6242 (1989).
15. Deffie A. M., Batra J. K., Goldenberg G. J., Cancer Res., 49, 58 (1989).
16. Liu L. F., Miller K. G., Proc. Natl. Acad. Sci. U.S.A., 78, 3487 (1981).
17. Kasahara K., Fujiwara Y., Sugimoto Y., J. Natl. Cancer Inst., 84, 113 (1992).
18. Safa A. R., Glover C. J., Sewell J. L., Meyers M. B., Biedler L. J., Felsted R. L., J. Biol. Chem., 262, 7884 (1987).
19. Kaneda N., Nagata H., Furuta T., Yokokura T., Cancer Res., 50, 21715 (1990).
20. Liu L. F., Annu. Rev. Biochem., 58, 351 (1989).
21. Mellado W., Horwitz S. B., Biochemistry, 26, 6900 (1987).
22. Epand R. M., Stafford A. R., Cancer J., 6, 154 (1993).
23. Hagiwara M., Wakusawa S., Miyamoto K., Hidaka H., Cancer Lett., 60, 103 (1991).